Attana

Russia
Artëm, Primorye, Russia, 191 62

Company profile

Attana company profile

Attana’s third generation biosensors are today used to determine specificity, kinetics and affinity -among other binding characteristics- of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria. their technology has been validated by academic institutions, biotech companies and big-pharma across the world.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2002-01-01, Year

Headquarters

Postal code
191 62
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Total equity funding
$2M
Last funding
Post IPO Equity / $1.3M / 2024-11-26
Last equity funding
Post IPO Equity / $1.3M
Investors
1
Lead investors
1
Founders
1
Articles
47
Exited on
2018-03-07

Founders and investors

Founders

Teodor Aastrup

Lead investors

Sciety

Investors

Sciety